TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
| Current price | $37.91 | 52-week high | $46.48 |
| Prev. close | $39.19 | 52-week low | $16.65 |
| Day low | $37.66 | Volume | 1,794,100 |
| Day high | $39.54 | Avg. volume | 2,466,882 |
| 50-day MA | $36.31 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 6.02B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
TGTX Price Returns
| 1-mo | 5.25% |
| 3-mo | -0.21% |
| 6-mo | 30.10% |
| 1-year | 80.52% |
| 3-year | 507.53% |
| 5-year | 70.00% |
| YTD | 25.95% |
| 2024 | 76.23% |
| 2023 | 44.38% |
| 2022 | -37.74% |
| 2021 | -63.48% |
| 2020 | 368.65% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...